Me In YYJ 🌻🕸️
9.4K posts

Me In YYJ 🌻🕸️
@MeInYYJ
Ideas and opinions from a small corner of the universe.





Nose grillz wasn’t on my 2026 bingo card 😭






📢💉🇨🇦Big update on Novavax / Nuvaxovid availability for Canada! Today, @SanofiCanada has announced, via @CNWNews, that they have completed the acquisition of Nuvaxovid market authorization from @Novavax and that Nuvaxovid will be available to Canadians in the fall. • Nuvaxovid will be made available in Canada by Sanofi for the fall 2026-2027 season • Provincial and territorial availability will be confirmed pending ongoing discussions and provincial assessments "With the launch of Nuvaxovid, a non-mRNA protein-based COVID-19 vaccine, Sanofi is now able to offer Canadians greater choice when it comes to COVID-19 protection. The availability of Nuvaxovid means that every Canadian will have the opportunity to access their personal COVID-19 vaccine choice. Canadians have clearly expressed a need for a non-mRNA option when it comes to COVID-19 protection. With this transfer, Sanofi can now respond to that need." - Delphine Lansac, General Manager, Canada, Vaccines at Sanofi. Press release: newswire.ca/news-releases/… Sanofi appears to have created a webpage for the Canadian product here, which includes the current product monograph: sanofi.com/en/canada/your…
















Novavax will be available in BC for the fall!!! My MLA’s constituency office sent me an email today confirming that it should be “available province-wide in select pharmacies.” Advocacy works! Thanks @Biff234523 @DoNoHarmBC @Friesein and all those who have raised your voice.

📢💉🇨🇦Big update on Novavax / Nuvaxovid availability for Canada! Today, @SanofiCanada has announced, via @CNWNews, that they have completed the acquisition of Nuvaxovid market authorization from @Novavax and that Nuvaxovid will be available to Canadians in the fall. • Nuvaxovid will be made available in Canada by Sanofi for the fall 2026-2027 season • Provincial and territorial availability will be confirmed pending ongoing discussions and provincial assessments "With the launch of Nuvaxovid, a non-mRNA protein-based COVID-19 vaccine, Sanofi is now able to offer Canadians greater choice when it comes to COVID-19 protection. The availability of Nuvaxovid means that every Canadian will have the opportunity to access their personal COVID-19 vaccine choice. Canadians have clearly expressed a need for a non-mRNA option when it comes to COVID-19 protection. With this transfer, Sanofi can now respond to that need." - Delphine Lansac, General Manager, Canada, Vaccines at Sanofi. Press release: newswire.ca/news-releases/… Sanofi appears to have created a webpage for the Canadian product here, which includes the current product monograph: sanofi.com/en/canada/your…





